For The First Time Ever, A Personalized mRNA Cancer Vaccine Has Cleared Phase 3 Trials – And With Flying Colors

Just a year after RFK Jr. cut half a billion of funding for the technology, mRNA vaccines are promising individualized cancer vaccines that cut the chances of recurrence in half.